Serum DBI and biomarkers of neuroinflammation in Alzheimer’s disease and delirium
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1590-3478
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Serum DBI and biomarkers of neuroinflammation in Alzheimer’s disease and delirium ; day:23 ; month:7 ; year:2020 ; pages:1-5
Neurological sciences ; (23.7.2020), 1-5
- Creator
-
Conti, Elisa
Andreoni, Simona
Tomaselli, Davide
Storti, Benedetta
Brovelli, Francesco
Acampora, Roberto
Da Re, Fulvio
Appollonio, Ildebrando
Ferrarese, Carlo
Tremolizzo, Lucio
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s10072-020-04608-x
- URN
-
urn:nbn:de:101:1-2020091622202181357481
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:52 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Conti, Elisa
- Andreoni, Simona
- Tomaselli, Davide
- Storti, Benedetta
- Brovelli, Francesco
- Acampora, Roberto
- Da Re, Fulvio
- Appollonio, Ildebrando
- Ferrarese, Carlo
- Tremolizzo, Lucio
- SpringerLink (Online service)
Other Objects (12)
Cerebrospinal Fluid S100B and Alzheimer’s Disease Biomarkers in Hip Fracture Patients with Delirium
Targeting Neuroinflammation to Treat Alzheimer’s Disease
Biomarkers in Alzheimer’s disease
Neuroinflammation and fractalkine signaling in Alzheimer’s disease
Exercise suppresses neuroinflammation for alleviating Alzheimer’s disease
Blood biomarkers for Alzheimer’s disease
Neuroimaging Biomarkers for Alzheimer’s Disease
Alzheimer’s disease: natural products as inhibitors of neuroinflammation
Multi-analyte proteomic analysis identifies blood-based neuroinflammation, cerebrovascular and synaptic biomarkers in preclinical Alzheimer’s disease
Current state of Alzheimer’s fluid biomarkers
Neuroinflammation in Alzheimer’s disease: insights from peripheral immune cells
Neuroinflammation, Its Role in Alzheimer’s Disease and Therapeutic Strategies
Cerebrospinal Fluid S100B and Alzheimer’s Disease Biomarkers in Hip Fracture Patients with Delirium
Targeting Neuroinflammation to Treat Alzheimer’s Disease
Biomarkers in Alzheimer’s disease
Neuroinflammation and fractalkine signaling in Alzheimer’s disease
Exercise suppresses neuroinflammation for alleviating Alzheimer’s disease
Blood biomarkers for Alzheimer’s disease
Neuroimaging Biomarkers for Alzheimer’s Disease
Alzheimer’s disease: natural products as inhibitors of neuroinflammation
Multi-analyte proteomic analysis identifies blood-based neuroinflammation, cerebrovascular and synaptic biomarkers in preclinical Alzheimer’s disease
Current state of Alzheimer’s fluid biomarkers
Neuroinflammation in Alzheimer’s disease: insights from peripheral immune cells
Neuroinflammation, Its Role in Alzheimer’s Disease and Therapeutic Strategies
Cerebrospinal Fluid S100B and Alzheimer’s Disease Biomarkers in Hip Fracture Patients with Delirium
Targeting Neuroinflammation to Treat Alzheimer’s Disease
Biomarkers in Alzheimer’s disease
Neuroinflammation and fractalkine signaling in Alzheimer’s disease
Exercise suppresses neuroinflammation for alleviating Alzheimer’s disease
Blood biomarkers for Alzheimer’s disease
Neuroimaging Biomarkers for Alzheimer’s Disease
Alzheimer’s disease: natural products as inhibitors of neuroinflammation
Multi-analyte proteomic analysis identifies blood-based neuroinflammation, cerebrovascular and synaptic biomarkers in preclinical Alzheimer’s disease
Current state of Alzheimer’s fluid biomarkers
Neuroinflammation in Alzheimer’s disease: insights from peripheral immune cells